Thermo Fisher Scientific Partners with NVIDIA to Revolutionize Laboratory Automation through AI

On January 12, 2026, Thermo Fisher Scientific Inc. (NYSE: TMO), the global leader in serving science, announced a groundbreaking collaboration with NVIDIA aimed at harnessing the power of artificial intelligence (AI) to enhance scientific instrumentation and boost laboratory performance. This strategic alliance promises to significantly modernize laboratory workflows, elevate automation, and improve the accuracy and speed of scientific research.

In the current landscape of scientific research, many tasks remain labor-intensive, requiring scientists to perform activities manually—from designing experiments to interpreting results. The collaboration between Thermo Fisher and NVIDIA aims to transform these traditional methodologies by integrating advanced AI capabilities and automation into laboratory processes. This initiative is expected to streamline operations, allowing scientists to focus on more complex analytical tasks and accelerate the pace of scientific discovery.

Thermo Fisher plans to integrate its extensive expertise in scientific instruments and laboratory software with NVIDIA's AI infrastructure. This includes leveraging powerful tools such as NVIDIA DGX Spark™, a desktop supercomputer, and AI models like NVIDIA NeMo™ and NVIDIA BioNeMo™. The goal is to create an intuitive user experience that democratizes scientific discovery, making advanced technological capabilities accessible to a wider range of researchers.

Gianluca Pettiti, Executive Vice President at Thermo Fisher, expressed enthusiasm for the collaboration, stating, "Artificial intelligence coupled with laboratory automation will transform how scientific work is performed." He emphasized that by merging Thermo Fisher's leadership in laboratory technologies with NVIDIA’s digital and AI solutions, the partnership will enable customers to work faster while enhancing accuracy and maximizing the value derived from each experiment. This, he noted, could lead to significant breakthroughs with profound human impact.

Kimberly Powell, Vice President of Healthcare at NVIDIA, added, "We are entering the era of ‘lab-in-the-loop’ science where the trinity of AI, agents, and instruments will be able to scale scientific discovery at industrial pace." She highlighted that this collaboration will lay the foundational infrastructure for autonomous laboratories, thereby creating a powerful research and discovery ecosystem that accelerates life sciences breakthroughs.

This partnership not only reinforces Thermo Fisher's position as a leading provider of cutting-edge instruments, equipment, and consumables in the life sciences sector but also enhances its existing ecosystem of technology partners. By integrating AI into laboratory environments, Thermo Fisher aims to create a unified platform where data, instruments, software, and scientists collaborate seamlessly, dramatically amplifying productivity within laboratories.

Thermo Fisher Scientific is recognized as the world's premier organization serving science, boasting annual revenues exceeding $40 billion. The company is dedicated to enabling customers to create a healthier, cleaner, and safer world. Whether through life sciences research, diagnostics, or the development of transformative therapies, Thermo Fisher supports a wide array of scientific endeavors. Its extensive portfolio includes renowned brands such as Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD.

The strategic collaboration between Thermo Fisher Scientific and NVIDIA marks a significant step forward in the integration of AI within laboratory environments. By enhancing automation and streamlining scientific workflows, this partnership aims to empower researchers to achieve greater efficiency and innovation in their work. As the life sciences landscape continues to evolve, the implications of this collaboration could lead to transformative discoveries that have far-reaching benefits for society.